Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343473 · ClinicalTrials.gov registry record
Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 22
- Enrollment target
NCT00343473 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 22 participants.
The verdict
NCT00343473 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in the back of the eye) due to diabetes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-10 |
| Est. Completion | 2024-02-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343473
The ClinicalTrials.gov registry entry for NCT00343473 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00343473 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343473 about?
NCT00343473 is a clinical study titled "Novel Diagnostics With Optical Coherence Tomography: Imaging the Anterior Eye". The purpose of this research is to evaluate the optical coherence tomography (OCT), to image diseases of the eye. OCT may be useful for the early diagnosis and monitoring of a variety of diseases involving the eye, such as Fuch's Dystrophy (type of eye disease) and retinal damage (eye diseases in th...
What is the current status of trial NCT00343473?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2005-10. Estimated completion is 2024-02-14.
Who is sponsoring clinical trial NCT00343473?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.